|4Apr 28, 4:52 PM ET

Gross Jane A 4

4 · aTYR PHARMA INC · Filed Apr 28, 2023

Insider Transaction Report

Form 4
Period: 2023-04-26
Gross Jane A
Director
Transactions
  • Exercise/Conversion

    Common stock

    2023-04-26+6,0006,000 total
  • Exercise/Conversion

    Restricted Stock Unit

    2023-04-266,0000 total
    Common Stock (6,000 underlying)
Footnotes (3)
  • [F1]Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.
  • [F2]RSUs convert into common stock on a one-for-one basis.
  • [F3]The RSUs fully vested one year from the grant date which was April 26, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION